Clinical Trial Update: SWITCH: Apixaban vs Vitamin K in HM3 [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating apixaban vs vitamin K in patients with LVAD-associated thrombosis and heart failure; the study is currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Stroke

Drugs mentioned

• Eliquis (apixaban)
• Vitamin K (Vitamin K)

Snippet

Sponsor: Columbia University | Conditions: LVAD (Left Ventricular Assist Device) Thrombosis, Heart Failure | Phase 3 | Status: NOT_YET_RECRUITING